Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1326.1000 12.80 (0.97%)

NSE Jun 19, 2025 15:31 PM

30.01% Gain from 52W Low

Volume: 1.7M

Dr. Reddy's Laboratories Ltd.

20 May 2022, 12:00AM

1326.10

0.97%

Dr Reddy's Labs (HOLD): Operating performance in line; impairment weighs down profit

Hold: Dr. Reddy's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

India, Russia, US and one-off opportunities drove 15% YoY sales growth in Q4; non-core brands divested in Russia and India

Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr